Two monitoring methods of oral anticoagulant therapy in patients with mechanical heart valve prothesis: A meta-analysis

Journal of Thrombosis and Thrombolysis

Volumn 33, Issue 1, 2012, Pages 38-47

  Xu, Zhe ^a   Wang, Zhiping ^a   Ou, Jingsong ^a   Xu, Yingqi ^a   Yang, Song ^a   Zhang, Xi ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Anticoagulants; Coumarins; Heart valve prosthesis implantation; Meta analysis; Self care; Vitamin K

Indexed keywords

ANTICOAGULANT AGENT; WARFARIN;

ARTICLE; BIBLIOGRAPHIC DATABASE; BLEEDING; HEALTH CARE QUALITY; HUMAN; INTERNATIONAL NORMALIZED RATIO; META ANALYSIS; MORTALITY; PATIENT EDUCATION; PATIENT MONITORING; PRIORITY JOURNAL; PROSTHETIC VALVE THROMBOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SELF CARE; SELF MONITORING; SYSTEMATIC REVIEW;

ADMINISTRATION, ORAL; ANTICOAGULANTS; DRUG MONITORING; HEART VALVE PROSTHESIS; HUMANS; INTERNATIONAL NORMALIZED RATIO; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SELF CARE;

EID: 84858863145     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/s11239-011-0626-1     Document Type: Article

References (52)

1. Altman LK (2008) 4 winners of Lasker medical prize. New York Times. http://www.nytimes.com/2007/09/16/health/16lasker.htm. Accessed 22 Jan 2008
2. Yacoub MH, Takkenberg JJM (2005) Will heart valve tissue engineering change the world? Nat Clin Pract Cardiovasc Med 2(2):60-61
3. Bonow RO, Carabello BA, Chatterjee K, de Leon AC, Faxon DP, Freed MD et al (2008) 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 guidelines for the management of patients with valvular heart disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 118(15):e523-e661
4. Mok CK, Boey J, Wang R, Chan TK, Cheung KL, Lee PK et al (1985) Warfarin versus dipyridamole-aspirin and pentoxifylline-aspirin for the prevention of prosthetic heart valve thromboembolism: a prospective randomised clinical trial. Circulation 72(5):1059-1063
5. Cobanoglu A, Fessler CL, Guvendik L, Grunkemeier G, Starr A (1988) Aortic valve replacement with the Starr-Edwards prosthesis: a comparison of the first and second decades of follow-up. Ann Thorac Surg 45(3):248-252
6. Bloomfield P, Wheatley DJ, Prescott RJ, Miller HC (1991) Twelve-year comparison of a Bjork-Shiley mechanical heart valve with porcine bioprostheses. N Engl J Med 324(9):573-579
7. O'Brien MF, Stafford EG, Gardner MA, Pohlner PG, Tesar PJ, Cochrane AD et al (1995) Allograft aortic valve replacement: long-term follow-up. Ann Thorac Surg 60(2 Suppl):S65-S70
8. Vongpatanasin W, Hillis LD, Lange RA (1996) Prosthetic heart valves. N Engl J Med 335(6):407-416
9. Hammermeister K, Sethi GK, Henderson WG, Grover FL, Oprian C, Rahimtoola SH (2000) Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs randomized trial. J Am Coll Cardiol 36(4):1152-1158
10. Grunkemeier GL, Li HH, Naftel DC, Starr A, Rahimtoola SH (2000) Long-term performance of heart valve prostheses. Curr Probl Cardiol 25(2):73-154
11. Andersen PV, Aagaard J (2000) Low-dose warfarin in patients with carbomedics heart valve prostheses. Asian Cardiovasc Thorac Ann 8(1):11-14
12. Cannegieter SC, Rosendaal FR, Briet E (1994) Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation 89(2):635-641
13. Oberhardt BJ, Dermott SC, Taylor M, Alkadi ZY, Abruzzini AF, Gresalfi NJ (1991) Dry reagent technology for rapid, convenient measurements of blood coagulation and fibrinolysis. Clin Chem 37(4):520-526
14. Kapiotis S, Quehenberger P, Speiser W (1995) Evaluation of the new method Coagucheck for the determination of the prothrombin time from capillary blood: comparison with thrombo test on KC-1. Thromb Res 77(6):563-567
15. Machin SJ, Mackie IJ, Chitolie A, Lawrie AS (1996) Near patient testing (near-patient testing) in haemostasis - a synoptic review. Clin Lab Haematol 18(2):69-74
16. van den Besselaar AM (2001) Accuracy, precision, and quality control for point-of-care testing of oral anticoagulation. J Thromb Thrombolysis 12(1):35-40
17. Murray ET, Fitzmaurice DA, McCahon D (2004) Point of care testing for INR monitoring: where are we now? Br J Haematol 127(4):373-378
18. Poller L, Keown M, Chauhan N, van den Besselaar AM, Tripodi A, Shiach C et al (2003) Reliability of international normalised ratios from two point of care test systems: comparison with conventional methods. BMJ 327(7405):30
19. Ansell J, Jacobson A, Levy J, Völler H, Hasenkam JM (2005) International Self-Monitoring Association for Oral Anticoagulation. Guidelines for implementation of patient selftesting and patient self-management of oral anticoagulation. International consensus guidelines prepared by International Self-Monitoring Association for Oral Anticoagulation. Int J Cardiol 99(1):37-45
20. Heneghan C, Alonso-Coello P, Garcia-Alamino J, Perera R, Meats E, Glasziou P (2006) Self-monitoring of oral anticoagulation: a systematic review and meta-analysis. Lancet 367(9508):404-411
21. de Sola-Morales Serra O, Elorza Ricart JM (2005) Portable coagulometers: a systematic review of the evidence on self-management of oral anticoagulant treatment. Med Clin 124(9):321-325
22. Christensen TD, Johnsen SP, Hjortdal VE, Hasenkam JM (2007) Self-management of oral anticoagulant therapy: a systematic review and meta-analysis. Int J Cardiol 118(1):54-61
23. Garcia-Alamino JM, Ward AM, Alonso-Coello P, Perera R, Bankhead C, Fitzmaurice D et al (2010) Self-monitoring and self-management of oral anticoagulation. Cochrane Database Syst Rev (4):CD003839
24. Matchar DB, Jacobson A, Dolor R, Edson R, Uyeda L, Phibbs CS et al (2010) Effect of home testing of international normalized ratio on clinical events. N Engl J Med 363(17):1608-1620
25. Dickersin K, Manheimer E, Wieland S, Robinson KA, Lefebvre C, McDonald S (2002) Development of the Cochrane Collaboration's CENTRAL Register of controlled clinical trials. Eval Health Prof 25(1):38-64
26. Dickersin K, Scherer R, Lefebvre C (1994) Identifying relevant studies for systematic reviews. BMJ 309(6964):1286-1291
27. Glanville JM, Lefebvre C, Jeremy NVM, Camosso-Stefinovic J (2006) How to identify randomized controlled trials in MEDLINE: ten years on. J Med Libr Assoc 94(2):130-136
28. Koerfer R, Reiss N, Koertke H (2009) International normalized ratio patient self-management for mechanical valves: is it safe enough? Curr Opin Cardiol 24(2):130-135
29. Jadad AR, Moor RA, Carroll D et al (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17(1):1-12
30. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557-560
31. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177-188
32. Michael JB, Jonathan JD, Jesse AB et al (2007) Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events. Stat Med 26(1):53-77
33. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in metaanalysis detected by a simple, graphical test. BMJ 315(7109):629-634
34. Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50(4):1088-1101
35. Koertke H, Korfer R (2001) International normalized ratio self-management after mechanical heart valve replacement: is an early start advantageous? Ann Thorac Surg 72(1):44-48
36. Sidhu P, O'Kane HO (2001) Self-managed anticoagulation: results from a two-year prospective randomized trial with heart valve patients. Ann Thorac Surg 72(5):1523-1527
37. Horstkotte D, Piper C, Wiemer M (1998) Optimal frequency of patient monitoring and intensity of oral anticoagulation therapy in valvular heart disease. J Thromb Thrombolysis 5(Suppl 1(3)):19-24
38. Eitz T, Schenk S, Fritzsche D, Bairaktaris A, Wagner O, Koertke H et al (2008) International normalized ratio self-management lowers the risk of thromboembolic events after prosthetic heart valve replacement. Ann Thorac Surg 85(3):949-955
39. Soliman Hamad MA, van Eekelen E, van Agt T, van Straten AHM (2009) Self-management program improves anticoagulation control and quality of life: a prospective randomized study. Eur J Cardiothorac Surg 35(2):265-269
40. Koertke H, Zittermann A, Wagner O, Koerfer R (2007) Self-management of oral anticoagulation therapy improves long-term survival in patients with mechanical heart valve replacement. Ann Thorac Surg 83(1):24-29
41. Oake N, Jennings A, Forster AJ, Fergusson D, Doucette S, van Walraven C (2008) Anticoagulation intensity and outcomes among patients prescribed oral anticoagulant therapy: a systematic review and meta-analysis. CMAJ 179(3):235-244
42. van Walraven C, Oake N, Wells PS, Forster AJ (2007) Burden of potentially avoidable anticoagulant-associated hemorrhagic and thromboembolic events in the elderly. Chest 131(5):1508-1515
43. Sun JCJ, Davidson MJ, Lamy A, Eikelboom JW (2009) Anti-thrombotic management of patients with prosthetic heart valves: current evidence and future trends. Lancet 374(9689):565-576
44. Schulman S, Beyth RJ, Kearon C, Levine MN et al (2008) Hemorrhagic complications of anticoagulant and thrombolytic treatment. American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest 133(6):257S-298S
45. Schulman S (2003) Care of patients receiving long-term anticoagulant therapy. New Engl J Med 349(7):675-683
46. Koertke H, Zittermann A, Tenderich G, Wagner O, El-Arousy M, Krian A et al (2007) Low-dose anticoagulation in patients with mechanical heart valve prostheses: final report from the early self-management anticoagulation trial II. Eur Heart J 28(20):2479-2484
47. Butchart EG, Payne N, Li H-H, Keith B, Mandana K, Grunkemeier GL (2002) Better anticoagulation control improves survival after valve replacement. J Thorac Cardiovasc Surg 123(4):715-723
48. Samsa G, Matchar DB, Dolor RJ, Wiklund I, Hedner E, Wygant G et al (2004) A new instrument for measuring anticoagulationrelated quality of life: development and preliminary validation. Health Qual Life Outcomes 2:22
49. Hollis S, Campbell F (1999) What is meant by intention to treat analysis? Survey of published randomised controlled trials. BMJ 319(7211):670-674
50. Fitzmaurice DA, Gardiner C, Kitchen S, Mackie I, Murray ET, Machin SJ et al (2005) An evidence based review and guidelines for patient self-testing and management of oral anticoagulation. Br J Haematol 131(2):156-165
51. Wittkowsky AK, Sekreta CM, Nutescu EA, Ansell J (2005) Barriers to patient self-testing of prothrombin time: national survey of anticoagulation practitioners. Pharmacotherapy 25(2):265-269
52. Regier DA, Sunderji R, Lynd LD, Gin K, Marra CA (2006) Cost-effectiveness of self-managed versus physician-managed oral anticoagulation therapy. CMAJ 174(13):1847-1852